| Code | CSB-RA023978MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to BI-1910, designed for research targeting TNFRSF1B (Tumor Necrosis Factor Receptor Superfamily Member 1B), also known as TNFR2 or CD120b. TNFRSF1B is a cell surface receptor that binds tumor necrosis factor-alpha (TNF-α) and plays a crucial role in regulating immune responses, inflammation, and cell survival pathways. Unlike TNFRSF1A, which primarily mediates pro-inflammatory and apoptotic signals, TNFRSF1B predominantly activates anti-apoptotic pathways and supports regulatory T cell function. This receptor is implicated in various inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis, and has emerged as a target of interest in cancer immunology due to its expression on tumor cells and immunosuppressive cell populations.
BI-1910 serves as the reference antibody for this biosimilar product and has been utilized in studies investigating TNFRSF1B signaling mechanisms and its role in immune modulation. This antibody provides researchers with a valuable tool for exploring TNF receptor biology, evaluating therapeutic strategies targeting the TNF pathway, and investigating immune regulation in disease models.
There are currently no reviews for this product.